Boston Scientific (BSX) Goodwill (2009 - 2026)

Boston Scientific (BSX) has 18 years of Goodwill data on file, last reported at $18.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Goodwill rose 6.9% year-over-year to $18.5 billion; the trailing twelve-month figure through Mar 2026 stood at $18.5 billion (up 6.9% YoY), and the FY2025 full-year result was $18.3 billion, up 6.98% from the prior year.
• Goodwill climbed to $18.5 billion in Q1 2026, from $18.3 billion in the prior quarter.
• In the past five years, Goodwill ranged from a high of $18.5 billion in Q1 2026 to a low of $12.9 billion in Q3 2022.
• A 5-year average of $15.2 billion and a median of $14.4 billion in 2023 frame the typical range for Goodwill.
• Across the five-year window, Goodwill climbed 2.47% in 2023 and increased 25.55% in 2025, its largest moves.
• Tracing BSX's Goodwill over 5 years: stood at $12.9 billion in 2022, then gained by 11.35% to $14.4 billion in 2023, then gained by 18.78% to $17.1 billion in 2024, then grew by 6.98% to $18.3 billion in 2025, then gained by 1.39% to $18.5 billion in 2026.
• Business Quant data shows BSX's Goodwill at $18.5 billion in Q1 2026, $18.3 billion in Q4 2025, and $18.2 billion in Q3 2025.